ClinicalTrials.gg
Status unknownNCT06409793MOTAFITUpdated May 10, 2024

Motivating Adolescent Fitness

An interventional study of mHealth in Exercise Training, sponsored by University of British Columbia. Status unknown at 1 site in Canada. Open to participants aged 13 Years to 16 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-10.

Sponsored by University of British Columbia · Not applicable, Interventional, and Basic science

The sponsor has not verified this record recently (last verified May 2024), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
13 Years to 16 Years
Sex
All
01

Study summary

The researchers are investigating whether adding mobile technology to a home-based exercise counselling program makes it easier for youth to begin and maintain regular exercise. Participants who joins the study will receive exercise counselling from an exercise specialist, but half of all participants will receive mobile technology - a fitness watch - that links to a mobile phone App. The mobile App allows the exercise specialist to provide personalized feedback throughout the program via the fitness watch. The investigators are interested to know whether the fitness watch and mobile App will make it easier for youth to achieve their exercise goals. Both groups will be compared to an active control group, who will receive no exercise program.

Read the detailed description

Purpose:

The investigators aim to undertake an experimental trial using exercise training in adolescents, evaluating a theoretical model where mHealth technology, allowing biometric informed feedback and coaching, is incorporated into a structured home-based exercise and physical activity (PA) intervention. The overall objective is to have an evidence-based exercise and PA intervention ready to evaluate in a future randomised controlled trial (RCT).

Hypothesis:

It is hypothesized that this approach will increase both habitual PA and adherence to structured exercise of the appropriate intensity to promote improvements in cardiorespiratory fitness and vascular function.

Justification:

Current physical activity guidelines suggest adolescents should accumulate at least 60 minutes of moderate to vigorous physical activity (MVPA) per day. Yet globally, more than 80% of adolescents fail to achieve the recommended level of daily MVPA, and less than 25% of Canadian adolescents are sufficiently physically active. Adolescence is a time when sedentary habits predominantly manifest. Sedentary time increases by approximately 100 minutes/day between the ages 12 and 16 years, and there is a disproportionate number of inactive adolescent girls (82%) compared to boys (71%). Clearly current strategies to encourage appropriate levels of physical activity in adolescence are inadequate.

It is important to note that the current MVPA guidelines lack the intensity associated with the enhancement of cardiorespiratory fitness in youth (\~85-90% of heart rate maximum).Further, the extant data show that habitual physical activity is not related, or at best weakly related to direct laboratory measures of cardiorespiratory fitness in youth.

If we aspire to improve cardiorespiratory or vascular health in our younger population, we need to find ways to engage adolescents in sufficient exercise i.e., 40-60 minutes, 3 to 4 times per week at \~85-90% of heart rate maximum.

Objectives:

Primary Objective

1) Determine the number of sedentary adolescents that are eligible to participate, the proportion of these who would be willing to take part in this trial, and their characteristics, and the number of participants retained at 6-months.

Secondary Objectives

  1. Adherence to the exercise training.
  2. Estimate precision of potential outcome measures required for sample size estimations for the definitive RCT.
  3. Intervention acceptability

Research Design:

The study is a randomised controlled intervention, whereby participants will complete pre-randomisation baseline testing (T1) before a 3-month supported PA and exercise intervention is completed. Immediately post-intervention (T2) and 6-months after the intervention is completed

Statistical Analysis:

The proportion of eligible patients who consent to participate in the pilot will be presented, along with the proportions in each intervention group completing each follow up assessment and the reasons for withdrawal. Descriptive characteristics and outcome data will be summarized overall and by intervention group, as mean (standard deviation) for normally distributed continuous variables, median (interquartile range) for non-normally distributed continuous variables, and number (percentage) for categorical variables.

Interview data will be analysed using thematic analysis, which will allow the research team to discuss emerging themes and help the research team to explore the barriers and facilitators to the intervention and refine the theoretical model, assessing which elements of the intervention. are most effective for participants. As this is a pilot study there will be no formal comparisons between groups in the intervention.

02

Conditions studied

  • Exercise Training
03

In context

Lead sponsor

University of British Columbia is the lead sponsor of 1,335 studies on the registry; 256 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or Female
  • Aged 13-16 years
  • Be comfortable communicating in English

Exclusion criteria

Exclusion Criteria:

  • Aged \<13 or >16
  • Inability to increase level of activity or exercise
  • Not owning a smartphone/ or having no data plan or access to Wi-Fi
  • Currently meeting the recommended exercise guidelines
  • Have congenital cardiac abnormalities (e.g., tetralogy of Fallot)
  • Have a known respiratory disease (e.g., asthma)
  • Have a known metabolic disease (e.g., Type 1 diabetes)
  • Are pregnant
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    mHealth

    Participants will undertake a 3-month structured exercise and PA intervention, supported by an exercise specialist. Participants will have 5 exercise consultations. Participants will receive a personalised progressive exercise programme. The aim will be to increase exercise intensity and duration during the first 3-months; aiming to meet the aerobic training guidelines of 3-4 sessions of at least 40 minutes at 85-90% heart rate maximum or of vigorous intensity. During follow-up, the aim will be to at least maintain this level of exercise. Participants will receive 1) a wrist worn fitness watch (Polar Ignite), featuring a 3d accelerometer and optical heart rate monitor, and 2) a smartphone app for participants (Polar Flow - Sync \& Analyse). These will be synced, allowing data to be transferred to the exercise specialist, who will created monitor pre-set exercise sessions.

    Behavioral: mHealth

  • Active comparator
    Exercise Counselling

    Participants will undertake the same 3-month structured exercise and PA intervention, supported by an exercise specialist, but without the use of mHealth technology to support the prescription and adherence to the exercise. Participants will be monitored using a wrist worn fitness watch, but will not receive feedback or have pre-set exercise sessions through the mHealth technology

    Behavioral: mHealth

  • No intervention
    Active control

    Participants will receive no exercise or PA intervention. Participants will continue with regular PA behaviours as an active control comparator. Participants in the control group will be monitored at the start and the end of the 3 months intervention period (2 weeks) to determine habitual PA and exercise levels

Interventions

  • BehavioralmHealth

    A 3-month structured exercise and PA intervention, supported by an exercise specialist, with a 3-month follow-up

    Also known as: Exercise Counselling

06

What researchers measure

Primary outcomes

  1. Eligibility to participate in the intervention

    1. The number of adolescents approached and reasons for not joining the study 2. Number of participants approached to participate, percentage attending/ dropout throughout the intervention

    Time frame: Baseline, and follow up at weeks 4,8,12

  2. Enrolment in the intervention

    Percentage of adolescents attending at 3-month post and 6-month follow up and reasons for drop-out.

    Time frame: Baseline, week 12

Secondary outcomes

  1. Adherence

    Adherence to the exercise training. Assessed as the number of prescribed sessions completed (as a percentage), and as the percentage of each exercise session spent in desired heart rate zones (80-95% heart rate max).

    Time frame: 12 weeks

  2. Precision of potential outcome measures of cardiorespiratory fitness

    Estimate precision of potential outcome measures required for sample size estimations for the definitive RCT. Maximal oxygen uptake will be assessed on an bike ergometer ramp incremental test to exhaustion. This will be compared from pre compared to post intervention

    Time frame: Baseline, week 12, week 24

  3. Precision of potential outcome measures of peripheral vascular function

    Estimate precision of potential outcome measures required for sample size estimations for the definitive RCT. This is assessed using ultrasound to assess peripheral endothelial function of the brachial artery at baseline compared to post intervention and follow up assessment.

    Time frame: Baseline, week 12, week 24

  4. Precision of potential outcome measures of cerebrovascular function

    Cerebrovascular function will be assessed using ultrasound of the internal carotid artery and vertebral artery for measures of blood flow and shear rate. This will be compared from baseline to post intervention.

    Time frame: Baseline, week 12, week 24

  5. Acceptability of the exercise training program

    This will be assessed using validated PACES 5-point likert scales for enjoyment of exercise sessions, self efficacy, positive and negative affect and perceived behavioural control. These will be assessed on a 5 point scale from 1-5 of participants subjective feelings throughout the intervention, and compared to participants between different arms of the intervention

    Time frame: baseline, week 6 and week 12

07

Study locations

1 site
  • University of British Columbia
    Kelowna, British Columbia V1V 1V7, Canada
08

References and documents

Publications

  • Koep JL, Sansum KM, Low J, Smith KJ, Cocks M, McManus AM. Feasibility of a mobile health intervention to motivate adolescent fitness and high-intensity exercise adherence (Motivating Adolescent Fitness (MOTAFIT)): protocol for a randomised controlled trial. BMJ Open. 2026 Feb 10;16(2):e112546. doi: 10.1136/bmjopen-2025-112546. PubMed 41667175 ↗

Individual participant data

Plan to share: No — The data collected will be kept by Dr McManus and Dr Koep and written up for publication

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2024; primary completion for Aug 2025, 14 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 4, 2024
First posted
May 10, 2024
StartEst.
Jun 1, 2024
Primary completionEst.
Aug 31, 2025
CompletionEst.
Aug 31, 2025
Last update
May 10, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 10, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06409793
Collaborators
MOSS ROCK PARK FOUNDATION
Responsible party
Ai McManus (Professor, University of British Columbia) — Principal investigator
First posted
May 10, 2024
Start date
Jun 1, 2024 (estimated)
Primary completion
Aug 31, 2025 (estimated)
Completion
Aug 31, 2025 (estimated)
Last update
May 10, 2024

Study contacts

Jodie L Koep, PhD
Contact
jodie.koep@ubc.ca
1-250-807-9873
Kate Sansum, MSc
Contact
kate.sansum@ubc.ca
250-863-1621
Alison McManus, PhD
principal investigator · University of British Columbia- Okanagan

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion